Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma (Q39096809)

9 September 2017

Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma (English)

1 reference

9 September 2017

1 reference

S Ito

1

1 reference

9 September 2017

A Natsume

2

1 reference

9 September 2017

S Shimato

3

1 reference

9 September 2017

M Ohno

4

1 reference

9 September 2017

T Kato

5

1 reference

9 September 2017

P Chansakul

6

1 reference

9 September 2017

T Wakabayashi

7

1 reference

9 September 2017

S U Kim

8

1 reference

9 September 2017

6 November 2009

1 reference

9 September 2017

1 reference

9 September 2017

17

1 reference

9 September 2017

5

1 reference

9 September 2017

299-306

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2009.80

9 September 2017

0 references

cites work

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Gene therapy of experimental brain tumors using neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

A phase I clinical trial of interferon-beta gene therapy for high-grade glioma: novel findings from gene expression profiling and autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Human neural stem cells genetically modified for brain repair in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Second-generation interferons for cancer: clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

A phase I trial of Ad.hIFN-beta gene therapy for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.80

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2009.80

1 reference

9 September 2017

1 reference